http://byetta.legalview.com/news-articles/ 2012-02-23 http://byetta.legalview.com/news-articles/lizard-venom-offers-hope-for-parkinsons-disease-patients/1235888/ 2012-02-23 http://byetta.legalview.com/news-articles/streetinsidercom-barclays-maintains-an-overweight-rating-on-amylin-pha/1235887/ 2012-02-23 http://byetta.legalview.com/news-articles/amylin-pharmaceuticals-to-present-at-morgan-stanley-global-healthcare/1235886/ 2012-02-23 http://byetta.legalview.com/news-articles/a-potential-new-market-for-byetta/1235885/ 2012-02-23 http://byetta.legalview.com/news-articles/byetta-is-a-bad-drug/1235884/ 2012-02-23 http://byetta.legalview.com/news-articles/health-concerns-partially-cause-byetta-to-lose-ground-in-diabetes-mark/1235883/ 2012-02-23 http://byetta.legalview.com/news-articles/duration-4-study-results-bydureon-efficacy-and-tolerability-profile-ex/1197964/ 2012-02-23 http://byetta.legalview.com/news-articles/will-new-byetta-weekly-injection-carry-similar-concerns/1197963/ 2012-02-23 http://byetta.legalview.com/news-articles/medical-news-once-a-week-diabetes-drug-comparable-to-standard-meds-in/1197962/ 2012-02-23 http://byetta.legalview.com/news-articles/log-in-problems/1159837/ 2012-02-23 http://byetta.legalview.com/news-articles/byetta-rejected-by-fda-over-new-formula-newsome-law/1159836/ 2012-02-23 http://byetta.legalview.com/news-articles/fda-hedges-approval-of-long-acting-byetta-asks-amylin-for-more-informa/1159835/ 2012-02-23 http://byetta.legalview.com/news-articles/byetta-pancreatitis-case-offers-new-evidence-of-cause-newsome-law/1159834/ 2012-02-23